Genomic landscape of TP53-mutated myeloid malignancies

Mostrar otras versiones (1)

TP53-mutated myeloid malignancies are associated with complex cytogenetics and extensive structural variants, which complicates detailed genomic analysis by conventional clinical techniques. We performed whole-genome sequencing (WGS) of 42 acute myeloid leukemia (AML)/myelodysplastic syndromes (MDS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Abel, Haley J., Oetjen, Karolyn A., Miller, Christopher A., Ramakrishnan, Sai M., Day, Ryan B., Helton, Nichole M., Fronick, Catrina C., Fulton, Robert S., Heath, Sharon E., Tarnawsky, Stefan P., Nonavinkere Srivatsan, Sridhar, Duncavage, Eric J., Schroeder, Molly C., Payton, Jacqueline E., Spencer, David H., Walter, Matthew J., Westervelt, Peter, DiPersio, John F., Ley, Timothy J., Link, Daniel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Myeloid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425686/
https://www.ncbi.nlm.nih.gov/pubmed/37339484
http://dx.doi.org/10.1182/bloodadvances.2023010156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425686/
https://www.ncbi.nlm.nih.gov/pubmed/37339484
http://dx.doi.org/10.1182/bloodadvances.2023010156

Ejemplares similares